WallStSmart

Cross Country Healthcare Inc (CCRN)vsTenet Healthcare Corporation (THC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 2041% more annual revenue ($21.45B vs $1.00B). THC leads profitability with a 7.9% profit margin vs -9.8%. THC appears more attractively valued with a PEG of 4.31. THC earns a higher WallStSmart Score of 66/100 (B-).

CCRN

Hold

36

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.82

THC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 5.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCRNUndervalued (+39.9%)

Margin of Safety

+39.9%

Fair Value

$13.76

Current Price

$13.18

$0.58 discount

UndervaluedFair: $13.76Overvalued

Intrinsic value data unavailable for THC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCRN3 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.8210/10

Safe zone — low bankruptcy risk

THC4 strengths · Avg: 9.5/10
P/E RatioValuation
9.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
35.4%10/10

Every $100 of equity generates 35 in profit

EPS GrowthGrowth
87.6%10/10

Earnings expanding 87.6% YoY

Free Cash FlowQuality
$1.46B8/10

Generating 1.5B in free cash flow

Areas to Watch

CCRN4 concerns · Avg: 2.3/10
Market CapQuality
$407.14M3/10

Smaller company, higher risk/reward

PEG RatioValuation
11.462/10

Expensive relative to growth rate

Return on EquityProfitability
-31.5%2/10

ROE of -31.5% — below average capital efficiency

Revenue GrowthGrowth
-17.8%2/10

Revenue declined 17.8%

THC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.8%4/10

2.8% revenue growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

PEG RatioValuation
4.312/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CCRN

The strongest argument for CCRN centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.

Bear Case : CCRN

The primary concerns for CCRN are Market Cap, PEG Ratio, Return on Equity.

Bear Case : THC

The primary concerns for THC are Revenue Growth, Altman Z-Score, Profit Margin. Debt-to-equity of 2.74 is elevated, increasing financial risk.

Key Dynamics to Monitor

CCRN profiles as a turnaround stock while THC is a value play — different risk/reward profiles.

THC carries more volatility with a beta of 1.28 — expect wider price swings.

THC is growing revenue faster at 2.8% — sustainability is the question.

THC generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

THC scores higher overall (66/100 vs 36/100). CCRN offers better value entry with a 39.9% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cross Country Healthcare Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Cross Country Healthcare, Inc. provides talent management and other consulting services for healthcare clients in the United States. The company is headquartered in Boca Raton, Florida.

Visit Website →

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?